Tight blood glucose control with insulin in the ICU - Facts and controversies

Department of Intensive Care Medicine, Katholieke Universiteit Leuven, Leuven, Belgium.
Chest (Impact Factor: 7.13). 08/2007; 132(1):268-78. DOI: 10.1378/chest.06-3121
Source: PubMed

ABSTRACT Recently, the concept that stress hyperglycemia in critically ill patients is an adaptive, beneficial response has been challenged. Two large randomized studies demonstrated that maintenance of normoglycemia with intensive insulin therapy substantially prevents morbidity and reduces mortality in these patients. Since then, questions have been raised about the efficacy in general and in specific subgroups, and about the safety of this therapy with regard to potential harm of brief hypoglycemic episodes and of high-dose insulin administration. These issues are systematically addressed in relation to the available evidence. Intensive insulin therapy during intensive care is effective in reducing the mortality and morbidity of critical illness. The available randomized studies show that an absolute reduction in risk of hospital death of 3 to 4% is to be expected from this therapy in an intention-to-treat analysis. In order to confirm this survival benefit and assign it as statistically significant, future studies should be adequately powered, and hence sample size should be at least 5,000. The absolute reduction in the risk of death increases to approximately 8% when patients are treated with intensive insulin for at least 3 days. Data available thus far indicate that blood glucose control to strict normoglycemia is required to obtain the most clinical benefit. The risk of hypoglycemia increases with this therapy, but it remains unclear whether this is truly harmful in the setting of critical care.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Fine needle amperometric glucose sensors having outer membrane of heparin in addition of polyurethane/polydimethylsiloxane film were prepared and their glucose sensor properties were evaluated in phosphate buffer solution and in vivo monitoring by the implantation of the sensor in veins of rabbit ears. The sensitivity of the sensor was 2.2 mu A mM(-1) cm(-2) and the detection limit for glucose was 77 mu M (based on S/N = 3). Glucose sensors without heparin membrane showed glucose response on the day of implantation in vein, while reliable response was not obtained on the second day. On the other hand, the sensor with heparin outer membrane provided clear glucose response also after two days of implantation. This result indicated that the introduction of heparin membrane increased the biocompatibility of the sensor and improved the stability of sensor in vein.
    224th ECS Meeting; 10/2013
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This randomized controlled trial compared the use of an intensive and conventional insulin protocol on clinical outcomes in patients with severe sepsis and septic shock, in the first 72 hours. It was conducted at a university hospital in the city of São Paulo. Patients (n=46) were allocated into two groups: intensive glycemic (blood glucose between 80-110mg/dl) and conventional (180-220mg/dl). The Student's t-test and chi-square test were used for data analysis. A statistically significant (p<0.001) difference was observed in mean glycemia, but there was no difference in the variables of mean minimum arterial pressure (p=0.06) or maximum (p=0.11), serum creatinine (p=0,33) or in mortality (p=0.11). Although there was no difference between the groups regarding mortality, hemodynamic instability in the conventional group was longer and the only deaths occurred in it.
    Revista da Escola de Enfermagem da U S P 06/2013; 47(3):615-20. DOI:10.1590/S0080-623420130000300013 · 0.50 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Cardiovascular disease is the major cause of death and disability in the Western world. The main disease underlying cardiovascular disorders is atherosclerosis. Atherosclerosis is a systemic disease affecting numerous vascular beds, including the coronary and peripheral circulation i.e. cerebrovascular, aortic and lower limb arterial circulation. The global ageing phenomenon will further increase the burden of cardiovascular disease and also enforce a change in health care towards the elderly population. Peripheral arterial disease (PAD) is a common condition. Importantly, only 1 out of 9 patients with PAD are symptomatic while vascular morbidity and mortality is estimated to be similar in patients with symptomatic or asymptomatic PAD. This poses PAD to be a major health burden. Risk factors for atherosclerotic disease are common and polyvascular disease is highly prevalent in the PAD population. The prognosis of patients with PAD is predominantly determined by the presence and extent of the underlying ischemic heart disease (IHD). The estimated cardiovascular risk in PAD is, moreover, as high as in IHD.3,4 Mc Dermott and colleagues reported already in 1997 that PAD patients received less intensive drug treatment compared to IHD patients, irrespective of comparable risk. Additionally, in a large risk factor matched population, patients with IHD received more cardiac medications, compared with PAD patients (beta-blockers 74% vs. 34%, aspirin 88% vs. 40%, nitrates 37% vs. 19%, statins 67% vs. 29% and ACE-inhibitors 57% vs. 31%, respectively). The observed poor medical control of PAD patients may be an explanation for the worse outcome of PAD patients compared with IHD patients as observed by the study of Welten et al. The REACH registry showed that cardiovascular events increased in a stepwise fashion with the number of symptomatic vascular beds.4 The combined 1-year outcome of atherothrombotic events ranged from 17% in patients with PAD as a single affected vascular bed to 26% in patients with 3 diseased vascular beds. Patients with PAD undergoing vascular surgery are known to be at higher risk for both early and late cardiovascular events compared to patients with IHD.3,7 Hertzer’s landmark study in 1000 consecutive patients undergoing surgery for PAD who underwent preoperative cardiac catheterizations reported that only 8% had normal coronary arteries, and approximately one third had severe-correctable or severe-inoperable IHD.